Skip to main content

Advertisement

SpringerLink
Log in

Great Debate: The Surgeon’s Role in Locoregional Management of Stage IV Breast Cancer

  • Breast Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Khan SA, Stewart AK, Morrow M. Does aggressive local therapy improve survival in metastatic breast cancer? Surgery. 2002;132(4):620–6 (discussion 626-7).

    Article  PubMed  Google Scholar 

  2. King TA. Surgery for the Primary in Patients with Distant Metastases. In: JR Harris, ME Lippman, M Morrow, K Osborne, editors. Diseases of the Breast. 5th edn. Philadelphia: Lippincott, Williams, and Wilkins; 2014. p. 880–90.

    Google Scholar 

  3. Nguyen A, King TA. New insights on the role of surgery for the breast primary tumor in patients presenting with stage IV disease. Curr Breast Cancer Rep. 2017;9(2):137–47.

    Article  Google Scholar 

  4. Cady B. Basic principles in surgical oncology. Arch Surg. 1997;132(4):338–46. https://doi.org/10.1001/archsurg.1997.01430280012001.

    Article  CAS  PubMed  Google Scholar 

  5. Khan SA, Zhao F, Goldstein LJ, et al. Early local therapy for the primary site in de novo stage IV breast cancer: results of a randomized clinical trial (EA2108). J Clin Oncol. 2022;40(9):978–87. https://doi.org/10.1200/JCO.21.02006.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Iqbal J, Ginsburg O, Rochon PA, Sun P, Narod SA. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. JAMA. 2015;313(2):165–73. https://doi.org/10.1001/jama.2014.17322.

    Article  CAS  PubMed  Google Scholar 

  7. Andre F, Slimane K, Bachelot T, et al. Breast cancer with synchronous metastases: trends in survival during a 14-year period. J Clin Oncol. 2004;22(16):3302–8. https://doi.org/10.1200/jco.2004.08.095.

    Article  PubMed  Google Scholar 

  8. Dawood S, Broglio K, Ensor J, Hortobagyi GN, Giordano SH. Survival differences among women with de novo stage IV and relapsed breast cancer. Ann Oncol. 2010;21(11):2169–74. https://doi.org/10.1093/annonc/mdq220.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Soran A, Ozmen V, Ozbas S, et al. Randomized trial comparing resection of primary tumor with no surgery in stage IV breast cancer at presentation: protocol MF07-01. Ann Surg Oncol. 2018;25(11):3141–9. https://doi.org/10.1245/s10434-018-6494-6.

    Article  PubMed  Google Scholar 

  10. Badwe R, Hawaldar R, Nair N, et al. Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial. Lancet Oncol. 2015;16(13):1380–8. https://doi.org/10.1016/S1470-2045(15)00135-7.

    Article  PubMed  Google Scholar 

  11. Fitzal F, Bjelic-Radisic V, Knauer M, et al. Impact of breast surgery in primary metastasized breast cancer: outcomes of the prospective randomized phase III ABCSG-28 POSYTIVE trial. Ann Surg. 2019;269(6):1163–9. https://doi.org/10.1097/sla.0000000000002771.

    Article  PubMed  Google Scholar 

  12. Lu S, Wu J, Fang Y, et al. The impact of surgical excision of the primary tumor in stage IV breast cancer on survival: a meta-analysis. Oncotarget. 2017;9(14):11816–23.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Soran A, Dogan L, Isik A, et al. The effect of primary surgery in patients with de novo stage IV breast cancer with bone metastasis only (protocol BOMET MF 14–01): a multi-center, prospective registry study. Ann Surg Oncol. 2021;28(9):5048–57. https://doi.org/10.1245/s10434-021-09621-8.

    Article  PubMed  Google Scholar 

  14. Wu SG, Li H, Tang LY, et al. The effect of distant metastases sites on survival in de novo stage-IV breast cancer: a SEER database analysis. Tumour Biol. 2017;39(6):1010428317705082. https://doi.org/10.1177/1010428317705082.

    Article  CAS  PubMed  Google Scholar 

  15. Partain N, Postlewait LM, Teshome M, et al. The role of mastectomy in de novo stage IV inflammatory breast cancer. Ann Surg Oncol. 2021;28(8):4265–74. https://doi.org/10.1245/s10434-020-09392-8.

    Article  PubMed  Google Scholar 

  16. van Uden DJP, van Maaren MC, Strobbe LJA, et al. Better survival after surgery of the primary tumor in stage IV inflammatory breast cancer. Surg Oncol. 2020;33:43–50. https://doi.org/10.1016/j.suronc.2020.01.005.

    Article  PubMed  Google Scholar 

  17. Postlewait LM, Teshome M, Adesoye T, et al. Contralateral axillary metastasis in patients with inflammatory breast cancer. Ann Surg Oncol. 2021;28(13):8610–21. https://doi.org/10.1245/s10434-021-10148-1.

    Article  PubMed  Google Scholar 

  18. Magnoni F, Colleoni M, Mattar D, et al. Contralateral axillary lymph node metastases from breast carcinoma: is it time to review TNM cancer staging? Ann Surg Oncol. 2020;27(11):4488–99. https://doi.org/10.1245/s10434-020-08605-4.

    Article  PubMed  Google Scholar 

  19. Hortobagyi GN. Treatment of breast cancer. N Engl J Med. 1998;339(14):974–84.

    Article  CAS  PubMed  Google Scholar 

  20. Rapiti E, Verkooijen HM, Vlastos G, et al. Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis. J Clin Oncol. 2006;24(18):2743–9. https://doi.org/10.1200/jco.2005.04.2226.

    Article  PubMed  Google Scholar 

  21. Babiera GV, Rao R, Feng L, et al. Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor. Ann Surg Oncol. 2006;13(6):776–82. https://doi.org/10.1245/ASO.2006.03.033.

    Article  PubMed  Google Scholar 

  22. Fields RC, Jeffe DB, Trinkaus K, et al. Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage IV breast cancer after controlling for site of metastasis. Ann Surg Oncol. 2007;14(12):3345–51. https://doi.org/10.1245/s10434-007-9527-0.

    Article  PubMed  Google Scholar 

  23. Gnerlich J, Dueker JM, Jeffe DB, Deshpande AD, Thompson S, Margenthaler JA. Patient and tumor characteristics associated with primary tumor resection in women with stage iv breast cancer: analysis of 1988–2003 SEER data. Breast J. 2008;14(6):538–42.

    Article  PubMed  Google Scholar 

  24. Blanchard DK, Shetty PB, Hilsenbeck SG, Elledge RM. Association of surgery with improved survival in stage IV breast cancer patients. Ann Surg. 2008;247(5):732–8. https://doi.org/10.1097/SLA.0b013e3181656d32.

    Article  PubMed  Google Scholar 

  25. Bafford AC, Burstein HJ, Barkley CR, et al. Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival. Breast Cancer Res Treat. 2009;115(1):7–12. https://doi.org/10.1007/s10549-008-0101-7.

    Article  PubMed  Google Scholar 

  26. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985;312(25):1604–8. https://doi.org/10.1056/nejm198506203122504.

    Article  CAS  PubMed  Google Scholar 

  27. Dominici L, Najita J, Hughes M, et al. Surgery of the primary tumor does not improve survival in stage IV breast cancer. Breast Cancer Res Treat. 2011;129(2):459–65. https://doi.org/10.1007/s10549-011-1648-2.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Shien T, Mizutani T, Tanaka K, et al. A randomized controlled trial comparing primary tumor resection plus systemic therapy with systemic therapy alone in metastatic breast cancer (JCOG1017 PRIM-BC) [abstract]. J Clin Oncol. 2017;35(15 Suppl):TPS588.

    Article  Google Scholar 

  29. Shien T, Nakamura K, Shibata T, et al. A randomized controlled trial comparing primary tumour resection plus systemic therapy with systemic therapy alone in metastatic breast cancer (PRIM-BC): Japan clinical oncology group study JCOG1017. Jpn J Clin Oncol. 2012;42(10):970–3. https://doi.org/10.1093/jjco/hys120.

    Article  PubMed  Google Scholar 

  30. Chmura SJ, Winter KA, Woodward WA, et al. NRG-BR002: a phase IIR/III trial of standard of care systemic therapy with or without stereotactic body radiotherapy (SBRT) and/or surgical resection (SR) for newly oligometastatic breast cancer (NCT02364557) [abstract]. J Clin Oncol. 2022;40(16 Suppl):1007.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Anthony Lucci MD, FACS

  2. Department of Surgery, Yale School of Medicine, New Haven, CT, USA

    Leah S. Kim MD & Mehra Golshan MD, MBA, FACS

  3. Yale Comprehensive Cancer Center, New Haven, CT, USA

    Mehra Golshan MD, MBA, FACS

  4. Division of Breast Surgery, Department of Surgery, Brigham and Women’s Hospital, Boston, MA, USA

    Tari A. King MD, FACS, FSSO, FASCO

  5. Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA

    Tari A. King MD, FACS, FSSO, FASCO

  6. Harvard Medical School, Boston, MA, USA

    Tari A. King MD, FACS, FSSO, FASCO

Authors
  1. Anthony Lucci MD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leah S. Kim MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mehra Golshan MD, MBA, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tari A. King MD, FACS, FSSO, FASCO
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tari A. King MD, FACS, FSSO, FASCO.

Ethics declarations

Disclosure

Mehra Golshan reports research funding from the Breast Cancer Research Foundation and participation on a Scientific Advisory Board for Bertis. Tari A. King reports speaker honoraria and compensated service on the scientific Advisory Board of Exact Sciences. Anthony Lucci and Leah S. Kim have no disclosures to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This work was presented as a featured Great Debate at the Annual Society of Surgical Oncology Meeting on 24 March 2023 in Boston, MA, USA.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lucci, A., Kim, L.S., Golshan, M. et al. Great Debate: The Surgeon’s Role in Locoregional Management of Stage IV Breast Cancer. Ann Surg Oncol 30, 7000–7007 (2023). https://doi.org/10.1245/s10434-023-14134-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-023-14134-7

Search

Navigation